FIELD: medicine; pharmaceutics.
SUBSTANCE: group of inventions relates to pharmaceutics and medicine. Object 1 is a pharmaceutical composition having analgesic action, containing an active ingredient, that is an analgesic substance, which is a chelate complex of ouabain-Ca2+, and a pharmaceutically acceptable carrier. Objects 2 and 3 are methods of pain syndrome relief, consisting in activation of transducer non-pumping function of Na, K-ATPase, including introduction of pharmaceutical composition.
EFFECT: efficacy of the analgesic agent, which is a chelate complex of ouabain-Ca2+, capable of replacing opiates in clinical practice and does not cause negative side pharmacological effects, such as intoxication and addiction.
8 cl, 3 dwg, 2 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
SYNTHETIC ANALGESIC AGENT AND METHOD FOR TREATMENT BASED ON THIS AGENT | 2006 |
|
RU2322977C1 |
SYNTHETIC ANALGESIC MEANS OF PEPTIDE NATURE AND METHOD OF ITS USE | 2017 |
|
RU2656188C1 |
ANALGESIC AGENT AND THERAPY OF PAIN SYNDROME OF VARIOUS AETIOLOGIES BY USING SAID AGENT | 2007 |
|
RU2367432C2 |
6-(3,3-DIMETHYL-3,4-DIHYDROISOCHINOLIN-1-IL) AMINOHEXANE ACID AND PHARMACEUTICAL COMPOSITION ON ITS BASIS THAT HAVE ANALGETIC ACTIVITY | 2016 |
|
RU2648445C1 |
MEANS FOR OPIOID ABSTINENCE SYNDROME ARRESTING | 2017 |
|
RU2643588C1 |
ANALGESIC AGENT OF PEPTIDE STRUCTURE OF UNDERCAPEPTIDE CONTAINING D-OCTAARGININE VECTOR | 2013 |
|
RU2541127C1 |
ANALGESIC AGENT OF PEPTIDE STRUCTURE BASED ON TRIDECAPEPTIDE CONTAINING D-OCTAARGININE VECTOR | 2013 |
|
RU2538727C1 |
MEANS FOR EFFECTIVE CUPPING OF ACUTE AND/OR CHRONIC PAIN SYNDROME AND METHOD OF ITS APPLICATION | 2016 |
|
RU2622980C1 |
METHOD FOR ALLEVIATING PAIN FEELING BY APPLYING LASER CORRECTION TREATMENT | 2005 |
|
RU2296596C2 |
NEPHOPAM SUPPOSITORIES FOR THE TREATMENT OF ACUTE AND CHRONIC PAIN SYNDROME ON A LIPOPHILIC BASIS AND THE METHOD FOR THEIR PREPARATION | 2017 |
|
RU2661618C1 |
Authors
Dates
2024-07-18—Published
2023-01-10—Filed